BioSpace News Archive

Drug Development

MilliporeSigma Launches ADC ExpressTM Services to Accelerate Pre-clinical Conjugation Candidate Selection

MilliporeSigma introduced its ADC Express TM services for the rapid production of ADCs, which can reduce the time needed to produce development grade constructs for target molecule identification.

October 9, 2019
·
2 min read
BioCapital

Microbix Presenting Product Results at Industry Conference

Microbix Biosystems Inc. announces it is making two presentations about the performance of its in-vitro diagnostics quality products (IVD Controls) at the 11th European Meeting on Molecular Diagnostics (EMMD) in Noordwijk, The Netherlands, October 9-11, 2019.

October 9, 2019
·
4 min read
Policy

Biocardia Receives CE Mark Renewal For Helix Biotherapeutic Delivery Catheter And Morph Guide Catheter Through May 2024

BioCardia announced renewal of the CE Mark for the Helix™ Biotherapeutic Delivery Catheter and Morph® Universal Deflectable Guide Catheter, both used in the delivery of biotherapeutics to the heart.

October 9, 2019
·
5 min read
Biotech Bay

SymphonyRM’s AI-Powered Next Best Actions to Help Virtua Health Drive Personalized and Proactive Consumer Engagement

Virtua Health in New Jersey adopts data-science driven customer relationship management (CRM) to provide a streamlined and connected consumer experience

October 9, 2019
·
3 min read
Drug Development

Study data monitoring committee has confirmed the good tolerability of Clevegen up to 10mg/kg and confirmed Part I expansion to secure optimal dosing for part II of the MATINS study with advanced solid tumours

Faron Pharmaceuticals Oy announces feedback from the MATINS study data monitoring committee from the ongoing dose escalation study from part I of the MATINS trial.

October 9, 2019
·
7 min read
Policy

J&J Will Appeal $8 Billion Verdict of Claims Risperdal Caused Breast Growth

The jury found the company failed to warn patients of a side effect causing young men who used the drug to grow breasts (gynecomastia).

October 9, 2019
·
3 min read
·
Alex Keown
FDA

FDA Approves Clinuvel’s Scenesse for Extreme Light Sensitivity

Scenesse is an under-the-skin implant. The drug is the company’s only approved product.

October 9, 2019
·
2 min read
·
Mark Terry
BioMidwest

Top 10 Life Sciences Companies with ‘Most Interesting and Meaningful’ Work

In the latest Ideal Employer Survey, BioSpace readers chimed in their thoughts on which companies across the biotech and biopharma industries were doing the most interesting and meaningful work.

October 9, 2019
·
5 min read
·
Alex Keown
Policy

FDA Boosts Rare Disease Research with $15 Million in Grants

The grants were awarded through the FDA’s Orphan Products Clinical Trials Grants Program that was provided by Congress to specifically encourage the development of treatments for rare diseases.

October 9, 2019
·
3 min read
·
Alex Keown
BioSpace Global Roundup, Oct. 10

Companies from across the globe provide updates on their business and pipelines.

October 9, 2019
·
5 min read
·
Alex Keown